Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TIBIX | 29.69 | 0.07 | +0.24% |
| Thornburg Investment Income Builder I | |||
| FSTBX | 21.04 | N/A | N/A |
| Federated Hermes Global Allocation A | |||
| GSCYX | 16.83 | N/A | N/A |
| GuideStone Funds Small Cap Equity Instl | |||
| CWSIX | 13.49 | N/A | N/A |
| Carillon Chartwell Small Cap Value I | |||
| CIVGX | 19.25 | N/A | N/A |
| American Funds International Vntg 529-F2 | |||
A.I.dvisor tells us that BIOVF and INNPF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOVF and INNPF's prices will move in lockstep.
| Ticker / NAME | Correlation To BIOVF | 1D Price Change % | ||
|---|---|---|---|---|
| BIOVF | 100% | N/A | ||
| INNPF - BIOVF | 20% Poorly correlated | -0.94% | ||
| APNHY - BIOVF | 19% Poorly correlated | N/A | ||
| BIOGY - BIOVF | 11% Poorly correlated | N/A | ||
| BOIRF - BIOVF | 1% Poorly correlated | N/A | ||
| ARSUF - BIOVF | 1% Poorly correlated | N/A | ||
More | ||||